Edmond de Rothschild Venture Capital
Investor profile
Deals
12
distinct rounds
Companies
10
backed
Active span
2007–2024
18 yrs
Total round €
€312M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Amundi Private Equity Funds2
- Bpifrance2
- EMBL Ventures2
- Forbion2
- IDInvest Partners2
- Sofinnova Partners2
- Ysios Capital2
- 3i Group1
- Alto Invest1
- Caixa Capital Risc1
- Convent Capital1
- Delos Capital1
- Direct Investments1
- Gilde Healthcare1
- HHT1
- Index Ventures1
- Innogest Capital1
- iXO Private Equity1
- la Caixa1
- Lundbeckfond Ventures1
- Peakbridge1
- Seroba Life Sciences1
- Wellington Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| BE WTR | Switzerland | 1 | €42M |
| Allecra Therapeutics | Germany | 2 | €37M |
| Sanifit | Spain | 1 | €37M |
| FastBooking | France | 1 | €35M |
| Genticel | France | 2 | €34M |
| Medlumics | Spain | 1 | €34M |
| MedDay | France | 1 | €34M |
| Finsecur | France | 1 | €25M |
| GlycoVaxyn | Switzerland | 1 | €19M |
| GamaMabs Pharma | France | 1 | €15M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| BE WTR | Series C | €42M | 2024-10 |
| Sanifit | Series C | €37M | 2015-08 |
| FastBooking | Series B | €35M | 2007-09 |
| Medlumics | Series B | €34M | 2017-02 |
| MedDay | Series B | €34M | 2016-03 |
| Finsecur | Growth/Late | €25M | 2014-10 |
| Allecra Therapeutics | Series B | €22M | 2016-05 |
| GlycoVaxyn | Series B | €19M | 2009-02 |
| Genticel | Series D+ | €18M | 2013-03 |
| Genticel | Series C | €16M | 2010-03 |